Coleman Drake, Assistant Professor, University of Pittsburgh

Legalization Reduces Opiate Abuse ER Visits, Study Confirms

Want to reduce the harm of the opiate epidemic? Legalize cannabis.

A new study from the University of Pittsburgh confirms a belief long held by experts about cannabis for opiate addiction. It shows a link between state-level legalization and fewer opiate overdose emergency room visits.

The study’s lead author suggests that officials embrace federal cannabis legalization, for the sake of public health.

“This isn’t trivial,” said Coleman Drake, an assistant professor at Pitt’s Graduate School of Public Health. “A decline in opioid-related emergency department visits, even if only for six months, is a welcome public health development.”

The change only continues for six months after legalization, but there is more cause for hope. Researchers didn’t find any increase in overdose visits after states legalized adult-use cannabis. If cannabis led to harder drug use, as prohibitionists claim, an increase in overdoses would be noticeable. This adds further research disproving the so-called “gateway theory.”

“[W]e suspect that people who use opioids for pain relief are substituting with cannabis, at least temporarily,” Drake said in a statement. “States can fight the opioid epidemic by expanding access to opioid use disorder treatment and by decreasing opioid use with recreational cannabis laws. These policies aren’t mutually exclusive; rather, they’re both a step in the right direction.”

Coleman and his colleagues published the study yesterday in the journal, Health Economics. An abstract clarifies that the plant isn’t an effective treatment for opioid addiction on its own. However, cannabis did prove effective as a replacement for opiates to treat pain.

“Cannabis liberalization may offer some help in curbing the opioid epidemic,” said Drake.

Most states would welcome the 7.6% decrease in emergency room overdose visits found by Drake and his colleagues, Jiebing Wen, Jesse Hinde and Hefei Wen. The change occurred during the first six months after legal, adult-use cannabis laws took effect in four states– California, Maine, Massachusetts and Nevada.

Using the period between June 2019 and May 2020, the data suggests over 6,000 of the 81,000 national overdose deaths could have been prevented with federal cannabis legalization. A bill to legalize cannabis at the federal level is expected to be introduced later today by Senate Democrats.

Drake boasts a PhD in Health Services Research, Policy and Administration from the University of Minnesota. The study used data on ER visits in the four legal cannabis states and 25 others between 2011 and 2017.

  • Steep Hill, Pioneer of U.S. Cannabis Testing, to Open a Licensed Lab in Vermont
    Steep Hill, a leader in cannabis analytical testing, and the United States’ first commercial cannabis lab, expands with a new licensee partner into the state of Vermont. In 2004, Vermont legalized cannabis for medicinal use and more recently in 2020, Vermont became the 11th state to approve of adult use sales.
  • Cannabis World Congress & Business Expo returns to NYC in June
    Cannabis enthusiasts, investors and industry members will gather once again at the Jacob Javits Convention Center in New York City for the Cannabis World Congress & Business Expo from June 2 to 4, 2022. The three-day event will feature respected speakers, stimulating discussions and an expo floor with scores of cannabis businesses.
  • Last Prisoner Project: Taking Real Action to Help Cannabis Prisoners
    “It really remains a fundamental injustice,” said Stephen Post, of America’s criminalization of cannabis. “We’re really helping to try to turn around those injustices.” Post works as a campaign manager for Last Prisoner Project (LPP), a nonprofit assisting cannabis prisoners.
  • Cannabis advocates show support for planned MORE Act House vote
    As members of Congress announce that the Marijuana Opportunity Reinvestment and Expungement (MORE) Act will receive a floor vote next week, advocates are showing their support for the bill. With counterpart legislation expected soon in the Senate, groups like Marijuana Policy Project, NORML and Human Rights Watch have issued reports and statements.
  • Veteran-owned and operated cannabis company on a mission to heal
    Bryan Buckley founded Helmand Valley Growers Company (HVGC) out of a desire to share healing through cannabis. The chief executive told Profiles in Legalization how the cannabis industry found him during a February interview. He saw the damage being done by inadequate treatment of his fellow veterans.
  • Mississippi entrepreneurs face local “opt-out” bans of cannabis industry
    Despite voters overwhelmingly passing Initiative 65 to create a medical marijuana program in November 2020, the state supreme court struck it down on constitutional technicality. After months of uncertainty, Gov. Tate Reeves signed the Mississippi Medical Cannabis Act into law in February 2022. Now, some local business people hoping to get a foothold in the industry are being blocked by their elected officials.